Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.76B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$776M |
| 3 |
Alibaba
BABA
|
+$405M |
| 4 |
Stellantis
STLA
|
+$331M |
| 5 |
First Horizon
FHN
|
+$314M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.92B |
| 2 |
Microsoft
MSFT
|
+$1.8B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.1B |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$982M |
Sector Composition
| 1 | Technology | 22.73% |
| 2 | Financials | 14.83% |
| 3 | Healthcare | 10.55% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
BWX Technologies
BWXT
$15.9B
| $288K | ﹤0.01% |
5,348
-13,009
| -71% | -$701K |
|
3002
ProShares Ultra QQQ
QLD
$9.56B
| $288K | ﹤0.01% |
4,000
-90
| -2% | -$6.48K |
|
|
LMACA
3003
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
| $288K | ﹤0.01% |
+29,110
| New | +$288K |
|
|
JMIA
3004
Jumia Technologies
JMIA
$1.46B
| $287K | ﹤0.01% |
30,001
+5,216
| +21% | +$49.9K |
|
3005
Kymera Therapeutics
KYMR
$3.66B
| $287K | ﹤0.01% |
+6,777
| New | +$287K |
|
3006
Laureate Education
LAUR
$4.36B
| $285K | ﹤0.01% |
24,081
-116,382
| -83% | -$1.38M |
|
|
GNOG
3007
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $285K | ﹤0.01% |
+40,123
| New | +$285K |
|
3008
Credo Technology Group
CRDO
$29.8B
| $283K | ﹤0.01% |
+18,636
| New | +$283K |
|
3009
SelectQuote
SLQT
$356M
| $282K | ﹤0.01% |
+100,879
| New | +$282K |
|
3010
PJT Partners
PJT
$4.58B
| $279K | ﹤0.01% |
4,412
-26,728
| -86% | -$1.69M |
|
3011
Shore Bancshares
SHBI
$583M
| $279K | ﹤0.01% |
13,613
| – | – |
|
3012
Acadia Healthcare
ACHC
$2.04B
| $277K | ﹤0.01% |
4,238
-19,819
| -82% | -$1.3M |
|
3013
Security National Financial
SNFCA
$248M
| $277K | ﹤0.01% |
33,612
| – | – |
|
3014
AN2 Therapeutics
ANTX
$35.3M
| $275K | ﹤0.01% |
+18,220
| New | +$275K |
|
|
CTO
3015
CTO Realty Growth
CTO
$542M
| $275K | ﹤0.01% |
+12,483
| New | +$275K |
|
3016
Vanguard Value ETF
VTV
$147B
| $275K | ﹤0.01% |
1,857
| – | – |
|
|
EACPU
3017
DELISTED
Edify Acquisition Corp. Units
EACPU
| $275K | ﹤0.01% |
+28,000
| New | +$275K |
|
3018
Ashland
ASH
$2.37B
| $274K | ﹤0.01% |
2,783
-9,604
| -78% | -$946K |
|
3019
Theravance Biopharma
TBPH
$729M
| $274K | ﹤0.01% |
28,624
-65,785
| -70% | -$630K |
|
3020
Amneal Pharmaceuticals
AMRX
$3.08B
| $273K | ﹤0.01% |
65,745
-119,278
| -64% | -$495K |
|
3021
Taysha Gene Therapies
TSHA
$816M
| $273K | ﹤0.01% |
+44,387
| New | +$273K |
|
3022
Holley
HLLY
$411M
| $270K | ﹤0.01% |
+19,350
| New | +$270K |
|
3023
Personalis
PSNL
$516M
| $270K | ﹤0.01% |
32,999
-37,709
| -53% | -$309K |
|
3024
Red Robin
RRGB
$118M
| $270K | ﹤0.01% |
15,964
-11,946
| -43% | -$202K |
|
3025
Safe Bulkers
SB
$473M
| $270K | ﹤0.01% |
56,668
-75,165
| -57% | -$358K |
|